These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7427244)

  • 1. Low bioavailability as a cause of apparent failure of dihydroergotamine in orthostatic hypotension.
    Olver IN; Jennings GL; Bobik A; Esler M
    Br Med J; 1980 Jul; 281(6235):275-6. PubMed ID: 7427244
    [No Abstract]   [Full Text] [Related]  

  • 2. Low oral bioavailability of dihydroergotamine and first-pass extraction in patients with orthostatic hypotension.
    Bobik A; Jennings G; Skews H; Esler M; McLean A
    Clin Pharmacol Ther; 1981 Nov; 30(5):673-9. PubMed ID: 6794970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic effects of dihydroergotamine in patients with postural hypotension.
    Bevegård S; Castenfors J; Lindblad LE
    Acta Med Scand; 1974 Dec; 196(6):473-7. PubMed ID: 4456977
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dihydergot in the treatment of orthostatic dysregulation].
    Mishra BR
    Fortschr Med; 1979 Sep; 97(33):1436-40. PubMed ID: 488888
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of orthostatic hypotension with dihydroergotamine and caffeine.
    Hoeldtke RD; Cavanaugh ST; Hughes JD; Polansky M
    Ann Intern Med; 1986 Aug; 105(2):168-73. PubMed ID: 3729199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydroergotamine in idiopathic orthostatic hypotension: short-term intramuscular and long-term oral therapy.
    Fouad FM; Tarazi RC; Bravo EL
    Clin Pharmacol Ther; 1981 Dec; 30(6):782-9. PubMed ID: 7030580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of orthostatic circulatory lability. Oral dihydroergotamine in various galenic preparations in comparative studies on orthostasis reactions].
    Kayser-Petersen E
    Fortschr Med; 1978 Jul; 96(25):1339-42. PubMed ID: 669523
    [No Abstract]   [Full Text] [Related]  

  • 8. Circulatory effects of dihydroergotamine in patients with disturbed sympathetic vasomotor control with special reference to postural hypotension.
    Bevegård S; Castenfors J; Lindblad LE
    Cardiology; 1976; 61 suppl 1():322-32. PubMed ID: 975147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of dihydroergotamine in man.
    Little PJ; Jennings GL; Skews H; Bobik A
    Br J Clin Pharmacol; 1982 Jun; 13(6):785-90. PubMed ID: 7093108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of orthostatic hypotension with dihydroergotamine.
    Jennings G; Esler M; Holmes R
    Br Med J; 1979 Aug; 2(6185):307. PubMed ID: 476438
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative effects of clonidine and dihydroergotamine on venomotor tone and orthostatic tolerance in patients with severe hypoadrenergic orthostatic hypotension.
    Victor RG; Talman WT
    Am J Med; 2002 Apr; 112(5):361-8. PubMed ID: 11904110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Action of dihydroergotamine in severe orthostatic hypotension. 16 cases].
    Saïd G
    Presse Med; 1987 May; 16(17):800-3. PubMed ID: 2954090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypotonic orthostatic regulation disorders. Comparison of dihydroergotamine preparations with varying release of effective substances in the management of hypotonic orthostatic regulation disorders].
    Beck J; Schwaiger H
    ZFA (Stuttgart); 1978 Oct; 54(28):1454-9. PubMed ID: 695865
    [No Abstract]   [Full Text] [Related]  

  • 14. Dihydroergotamine therapy in orthostatic hypotension due to psychotropic drugs.
    Thulesius O; Berlin E
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):465-7. PubMed ID: 2877953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of dihydroergotamine in the prevention and treatment of orthostatic hypotension syndromes in patients with parkinsonism treated with L-dopa].
    Jubert Gruart J; Balcells Riba M
    Arch Neurobiol (Madr); 1974; 37(4):401-12. PubMed ID: 4433212
    [No Abstract]   [Full Text] [Related]  

  • 16. [What is the value of therapy with dihydroergotamine plus etilefrin in orthostatic circulation disorders].
    Schardt F
    Med Welt; 1981 Feb; 32(6):194-8. PubMed ID: 6110159
    [No Abstract]   [Full Text] [Related]  

  • 17. Dihydroergotamine treatment for orthostatic hypotension from Vacor rodenticide.
    Benowitz NL; Byrd R; Schambelan M; Rosenberg J; Roizen MF
    Ann Intern Med; 1980 Mar; 92(3):387-8. PubMed ID: 7356234
    [No Abstract]   [Full Text] [Related]  

  • 18. [Controlled comparison of dihydroergotamine and etilofrin in orthostatic syndrome].
    Garbe WE; Clasen J
    Med Welt; 1978 Jun; 29(22):939-42. PubMed ID: 26009
    [No Abstract]   [Full Text] [Related]  

  • 19. Haemodynamic effects of dihydroergotamine in orthostatic hypotension.
    Nordenfelt I; Mellander S
    Cardiology; 1976; 61 suppl 1():316-21. PubMed ID: 975146
    [No Abstract]   [Full Text] [Related]  

  • 20. [Orthostatic hypotension in the aged subject].
    de Brito Paiva E; Constantinescu M; Treuer E
    Rev Med Suisse Romande; 1983 Jan; 103(1):43-9. PubMed ID: 6133336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.